|
|
||||||||
Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis1



,¶
* Molecular Pathogenesis Program, Skirball Institute of Biomolecular Medicine,
Sackler Institute of Graduate Biomedical Sciences, and
Department of Pathology, New York University Medical Center, New York, NY 10016;
Division of Immunological Research, Schering-Plough Research Institute, Kennilworth, NJ 07033; and
¶ Neuropathology Service, Bellevue Hospital, New York, NY 10016
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory disease of the CNS initiated by autoreactive CD4+ T cells. EAE classically presents with a progressive ascending paralysis and is a model of multiple sclerosis that recapitulates some aspects of the disease. In this report we describe a mouse strain that spontaneously develops a severe, nonclassical form of EAE with 100% incidence. The distinct clinical phenotype is marked initially by a slight head tilt, progressing to a severe head tilt, spinning, or a rotatory motion. Classical EAE spontaneously occurs in myelin basic protein (MBP)-specific TCR transgenic RAG-1/ mice (referred to as T/R), whereas nonclassical EAE spontaneously occurs in T/R IFN-
/ mice (T/R
). Thus, the TCR recognizes the same Ag (MBP) and uses identical TCR in both cases. The cellular infiltrate in nonclassical EAE is predominantly found in the brainstem and cerebellum, with very little inflammation in the spinal cord, which is primarily affected in classical disease. Importantly, depending on the genetic makeup and priming conditions of the MBP-specific T cells, nonclassical disease can occur in the presence of an inflammatory infiltrate with eosinophilic, neutrophilic, or monocytic characteristics. Finally, we believe that nonclassical spontaneous EAE could be a useful model for the study of some characteristics of multiple sclerosis not observed in classical EAE, such as the inflammatory responses in the brainstem and cerebellum that can cause vertigo.
This article has been cited by other articles:
![]() |
S. Nessler, S. Boretius, C. Stadelmann, A. Bittner, D. Merkler, H.-P. Hartung, T. Michaelis, W. Bruck, J. Frahm, N. Sommer, et al. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage Brain, August 1, 2007; 130(8): 2186 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou, R. A. Gault, T. R. Kozel, and W. J. Murphy Protection from Direct Cerebral Cryptococcus Infection by Interferon-{gamma}-Dependent Activation of Microglial Cells J. Immunol., May 1, 2007; 178(9): 5753 - 5761. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Balabanov, K. Strand, R. Goswami, E. McMahon, W. Begolka, S. D. Miller, and B. Popko Interferon-{gamma}-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis J. Neurosci., February 21, 2007; 27(8): 2013 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tsunoda, J. E. Libbey, L.-Q. Kuang, E. J. Terry, and R. S. Fujinami Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis Am. J. Pathol., December 1, 2005; 167(6): 1631 - 1646. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |